For the nine months ended October 2026, consolidated results show net sales of 141,406 million yen (up 5.1% YoY), operating income of 7,628 million yen (down 26.7%), ordinary income of 12,205 million yen (up 5.5%), and net income attributable to owners of the parent of 5,725 million yen (down 36.7%). Full-year guidance revised to net sales of 175,000 million yen, operating income of 2,700 million yen, ordinary income of 8,500 million yen, and net income attributable to owners of the parent of 4,000 million yen. June-period earnings briefing materials and a results presentation will be prepared as scheduled. However, there are no major changes to the latest dividend forecast. Overseas sales ratio is 56.4%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4996","jir_company_name":"Kumiai Chemical Industry Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4996-20260911-01.pdf","jir_short_summary":"For the nine months ended October 2026, consolidated results show net sales of 141,406 million yen (up 5.1% YoY), operating income of 7,628 million yen (down 26.7%), ordinary income of 12,205 million yen (up 5.5%), and net income attributable to owners of the parent of 5,725 million yen (down 36.7%). Full-year guidance revised to net sales of 175,000 million yen, operating income of 2,700 million yen, ordinary income of 8,500 million yen, and net income attributable to owners of the parent of 4,000 million yen. June-period earnings briefing materials and a results presentation will be prepared as scheduled. However, there are no major changes to the latest dividend forecast. Overseas sales ratio is 56.4%.","jir_summary":"### Overview of Results\nKumiai Chemical posted consolidated net sales of 141,406 million yen for the nine-month period, up 5.1% YoY. However, operating income declined 26.7% YoY to 7,628 million yen due to inventory valuation losses, etc. Ordinary income rose 5.5% YoY to 12,205 million yen on foreign exchange gains, while net income attributable to owners of the parent decreased 36.7% YoY to 5,725 million yen due to structural reform costs. Overseas sales ratio stands at 56.4%. Preparation and disclosure of the earnings briefing materials will proceed as scheduled.\n\n### Outlook and Capital Policy\nFull-year guidance has been revised: net sales 175,000 million yen, operating income 2,700 million yen, ordinary income 8,500 million yen, and net income attributable to owners of the parent 4,000 million yen. There are no significant changes to the dividend forecast, and the current year-end dividend plan has been disclosed. As a material post-event, a simplified share exchange including three subsidiaries is planned, with the aim of making those three consolidated subsidiaries wholly owned subsidiaries.","jir_financial_highlights":"Net Sales: 141,406\u767e\u4e07\u5186 (YoY +5.1%)\nOperating Income: 7,628\u767e\u4e07\u5186 (YoY \u25b326.7%)\nOrdinary Income: 12,205\u767e\u4e07\u5186 (YoY +5.5%)\nNet income attributable to owners of the parent: 5,725\u767e\u4e07\u5186 (YoY \u25b336.7%)\nFull-year net sales: 175,000\u767e\u4e07\u5186 (Revision from previous forecast: yes)","jir_category":"","jir_hashtags":"#KumiaiChemicalIndustry, #Earnings, #MediumTermPlan, #StockExchange","jir_key_figures":"Net Sales: 141,406\u767e\u4e07\u5186\uff08YoY up 5.1\uff05\uff09\nOperating Income: 7,628\u767e\u4e07\u5186\uff08YoY \u25b326.7\uff05\uff09\nOrdinary Income: 12,205\u767e\u4e07\u5186\uff08YoY +5.5\uff05\uff09","jir_meta_title":"Kumiai Chemical Industry: Highlights from the Q3 Results and Full-Year Outlook | FY October 2026","jir_meta_description":"Key points from Kumiai Chemical Industry's Q3 FY2026 results. Net sales 141,406 million yen, operating income 7,628 million yen, revised full-year outlook. Overseas ratio 56.4%, plans to publish earnings briefing materials.","jir_og_title":"Kumiai Chemical Industry: Highlights from the Q3 Results and Full-Year Outlook","jir_og_description":"Kumiai Chemical Industry's nine-month results show higher net sales but lower profits. Full-year outlook revised, and plans to make three subsidiaries wholly owned via stock exchanges.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16678,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-112621","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n